强生公司计划分拆骨科业务,独立运营的骨科业务将以DePuy Synthes品牌运作

美股速递
Oct 14

强生公司(Johnson & Johnson)宣布有意分拆其骨科业务部门。根据该计划,分拆后的骨科业务将作为独立实体运营,并继续使用DePuy Synthes的品牌名称进行经营。

这一战略举措表明强生公司正在重新调整其业务结构,通过分拆骨科业务来优化公司的运营效率和市场定位。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10